<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The antibiotics and antifungals drugs (RA-rifampicin: 5 
 <italic class="italic">μ</italic>g, DA-clindamycin: 2 
 <italic class="italic">μ</italic>g, P-penicillin G: 10 IU, CLR-clarithromycin: 15 
 <italic class="italic">μ</italic>g, AMX-amoxicillin: 25 
 <italic class="italic">μ</italic>g, MTZ-metronidazole: 5 
 <italic class="italic">μ</italic>g, OXA-oxacillin: 5 
 <italic class="italic">μ</italic>g, TMP-trimethoprim: 5 
 <italic class="italic">μ</italic>g, SXT-trimethoprim-sulfamethoxazole: 1.25
 <italic class="italic">μ</italic>g/23.75
 <italic class="italic">μ</italic>g VAN-vancomycin: 30 
 <italic class="italic">μ</italic>g, AMB-amphotericin: B: 100 
 <italic class="italic">μ</italic>g, FLC-fluconazole: 25 
 <italic class="italic">μ</italic>g, and KTC-ketoconazole: 15 
 <italic class="italic">μ</italic>g) were used as positive control. The logic of selection of these antibiotics was based on the antibiotic susceptibility testing.
</p>
